[go: up one dir, main page]

WO2003066652A3 - Jlp cytoplasmic scaffolding protein and nucleic acids encoding it - Google Patents

Jlp cytoplasmic scaffolding protein and nucleic acids encoding it Download PDF

Info

Publication number
WO2003066652A3
WO2003066652A3 PCT/US2003/003355 US0303355W WO03066652A3 WO 2003066652 A3 WO2003066652 A3 WO 2003066652A3 US 0303355 W US0303355 W US 0303355W WO 03066652 A3 WO03066652 A3 WO 03066652A3
Authority
WO
WIPO (PCT)
Prior art keywords
jlp
nucleic acids
scaffolding protein
acids encoding
cytoplasmic scaffolding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2003/003355
Other languages
French (fr)
Other versions
WO2003066652A2 (en
WO2003066652A8 (en
Inventor
Clement M Lee
N Dhanasekaran
Premkumar E Reddy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Temple Univ School of Medicine
Original Assignee
Temple Univ School of Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Temple Univ School of Medicine filed Critical Temple Univ School of Medicine
Priority to AU2003216170A priority Critical patent/AU2003216170A1/en
Publication of WO2003066652A2 publication Critical patent/WO2003066652A2/en
Publication of WO2003066652A3 publication Critical patent/WO2003066652A3/en
Publication of WO2003066652A8 publication Critical patent/WO2003066652A8/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4747Apoptosis related proteins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

A cytoplasmic scaffolding protein named JLP has been isolated, which tethers MEKK3, MKK4, JNK,p38 MAPK, C-Myc and MAX into a sign aling module that controls the apoptotic response. Nucleic acid sequences which encode JLP, and methods of using the JLP nucleic acids and proteins, and mutants thereof, to modulate the apoptotic response in cells are provided.
PCT/US2003/003355 2002-02-05 2003-02-04 Jlp cytoplasmic scaffolding protein and nucleic acids encoding it Ceased WO2003066652A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003216170A AU2003216170A1 (en) 2002-02-05 2003-02-04 Jlp cytoplasmic scaffolding protein and nucleic acids encoding it

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35437702P 2002-02-05 2002-02-05
US60/354,377 2002-02-05

Publications (3)

Publication Number Publication Date
WO2003066652A2 WO2003066652A2 (en) 2003-08-14
WO2003066652A3 true WO2003066652A3 (en) 2003-10-30
WO2003066652A8 WO2003066652A8 (en) 2004-02-19

Family

ID=27734363

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2003/003355 Ceased WO2003066652A2 (en) 2002-02-05 2003-02-04 Jlp cytoplasmic scaffolding protein and nucleic acids encoding it

Country Status (2)

Country Link
AU (1) AU2003216170A1 (en)
WO (1) WO2003066652A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090042805A1 (en) * 2004-11-24 2009-02-12 David Chauvier Peptides Useful As Dual Caspase-2/-6 Inhibitors And Their Biological Applications

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998030589A2 (en) * 1997-01-10 1998-07-16 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them
WO2001057188A2 (en) * 2000-02-03 2001-08-09 Hyseq, Inc. Novel nucleic acids and polypeptides

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998030589A2 (en) * 1997-01-10 1998-07-16 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them
WO2001057188A2 (en) * 2000-02-03 2001-08-09 Hyseq, Inc. Novel nucleic acids and polypeptides

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DATABASE GENBANK [online] NAGASE ET AL.: "Prediction of the coding sequences of unidentified human genes. IX. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro", XP002967298, Database accession no. (AB011088) *
DNA RES., vol. 5, no. 1, 28 February 1998 (1998-02-28), pages 31 - 39 *

Also Published As

Publication number Publication date
AU2003216170A1 (en) 2003-09-02
AU2003216170A8 (en) 2003-09-02
WO2003066652A2 (en) 2003-08-14
WO2003066652A8 (en) 2004-02-19

Similar Documents

Publication Publication Date Title
WO2002090600A3 (en) A method for regulating immune function in primates using the foxp3 protein
WO2002005146A3 (en) Method for disigning protein libraries with altered immunogenicity
WO2004022593A3 (en) Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules
AU2003225644A1 (en) Wax ester synthase dna sequence, protein and uses thereof
WO2004033668A8 (en) Proteases, nucleic acids encoding them and methods for making and using them
WO2003093296A3 (en) Kinase anchor protein muteins, peptides thereof, and related methods
AU2003267094A1 (en) System and methods for electrophoretic separation of proteins on protein binding membranes
WO2005061716A3 (en) Expression vector used for antibiotic-free expression
WO2002046465A3 (en) Method for identification of genes involved in specific diseases
WO2004029208A3 (en) Cell separation compositions and methods
WO2003014303A3 (en) Molecular interactions in cells
WO2003006154A3 (en) Protein design automation for designing protein libraries with altered immunogenicity
WO1998008961A3 (en) Endosperm and nucellus specific genes, promoters and uses thereof
AU2003252111A1 (en) Fluorescent proteins, nucleic acids encoding them and methods for making and using them
WO2003066652A3 (en) Jlp cytoplasmic scaffolding protein and nucleic acids encoding it
WO1999047558A3 (en) T cell costimulatory proteins, sequences and uses thereof
WO2000045179A3 (en) Screening for modulators of g-protein subunit beta 3
AU2001238064A1 (en) 18477, a human protein kinase and uses therefor
WO2005092918A3 (en) Targeting polypeptide
CA2478659A1 (en) Electrophoretic buffer
WO2005007803A3 (en) Selection free growth of host cells containing multiple integrating vectors
WO2004067750A3 (en) Xenorhabdus tc proteins and genes for pest control
WO2003000901A8 (en) Nucleic acids encoding protein kinases
WO2005059101A3 (en) Novel sodium channel
WO2002002771A3 (en) Human sparc-homologous (hsparc-h1) gene and methods and uses thereof

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WR Later publication of a revised version of an international search report
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP